Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study

被引:160
作者
Khalili, Hamed [1 ]
Huang, Edward S. [1 ]
Jacobson, Brian C. [2 ]
Camargo, Carlos A., Jr. [3 ,4 ,5 ]
Feskanich, Diane [4 ,5 ]
Chan, Andrew T. [1 ,4 ,5 ]
机构
[1] Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA
[2] Boston Univ, Med Ctr, Sect Gastroenterol, Boston, MA 02118 USA
[3] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
[4] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA
[5] Harvard Univ, Sch Med, Boston, MA USA
来源
BRITISH MEDICAL JOURNAL | 2012年 / 344卷
基金
美国国家卫生研究院;
关键词
INTESTINAL CALCIUM-ABSORPTION; FOOD FREQUENCY QUESTIONNAIRE; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; REPRODUCIBILITY; OMEPRAZOLE; MORTALITY; VALIDITY; SMOKING; METAANALYSIS;
D O I
10.1136/bmj.e372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine the association between chronic use of proton pump inhibitors (PPIs) and risk of hip fracture. Design Prospective cohort study. Setting Nurses' Health Study, which originally recruited from the 11 most populous states in the US. Participants 79 899 postmenopausal women enrolled in the Nurses' Health Study who provided data on the use of PPIs and other risk factors biennially since 2000 and were followed up to 1 June 2008. Main outcome measure Incident hip fracture Results During 565 786 person years of follow-up, we documented 893 incident hip fractures. The absolute risk of hip fracture among regular users of PPIs was 2.02 events per 1000 person years, compared with 1.51 events per 1000 person years among non-users. Compared with non-users, the risk of hip fracture among women who regularly used PPIs for at least two years was 35% higher (age adjusted hazard ratio 1.35 (95% confidence interval 1.13 to 1.62)), with longer use associated with increasing risk (P-trend<0.01). Adjustment for risk factors, including body mass index, physical activity, and intake of calcium did not materially alter this association (hazard ratio 1.36 (1.13 to 1.63)). These associations were also not changed after accounting for reasons for PPI use. The relation between PPI use and fracture differed by smoking history (P-interaction=0.03). Among current and former smokers, PPI use was associated with greater than 50% increase in risk of fracture, with a multivariate hazard ratio for fracture of 1.51 (1.20 to 1.91). In contrast, among women who never smoked there was no association (multivariate hazard ratio 1.06 (0.77 to 1.46)). In a meta-analysis of these results with 10 prior studies, the pooled odds ratio of hip fracture associated with PPI use was 1.30 (1.25 to 1.36). Conclusion Chronic use of PPIs is associated with increased risk of hip fracture, particularly among women with a history of smoking.
引用
收藏
页数:13
相关论文
共 43 条
[1]  
[Anonymous], 1992, AM J EPIDEMIOL
[2]   Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women [J].
Bliuc, Dana ;
Nguyen, D. Nguyen ;
Milch, Vivienne E. ;
Nguyen, Tuan V. ;
Eisman, John A. ;
Center, Jacqueline R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (05) :513-521
[3]   Incidence and Mortality of Hip Fractures in the United States [J].
Brauer, Carmen A. ;
Coca-Perraillon, Marcelo ;
Cutler, David M. ;
Rosen, Allison B. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (14) :1573-1579
[4]   A prospective study of aspirin use and the risk for colorectal adenoma [J].
Chan, AT ;
Giovannucci, EL ;
Schernhammer, ES ;
Colditz, GA ;
Hunter, DJ ;
Willett, WC ;
Fuchs, CS .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (03) :157-166
[5]   Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study [J].
Chiu, Hui-Fen ;
Huang, Ya-Wen ;
Chang, Chih-Ching ;
Yang, Chun-Yuh .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (11) :1131-1136
[6]   VALIDATION OF QUESTIONNAIRE INFORMATION ON RISK-FACTORS AND DISEASE OUTCOMES IN A PROSPECTIVE COHORT STUDY OF WOMEN [J].
COLDITZ, GA ;
MARTIN, P ;
STAMPFER, MJ ;
WILLETT, WC ;
SAMPSON, L ;
ROSNER, B ;
HENNEKENS, CH ;
SPEIZER, FE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 123 (05) :894-900
[7]   Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients [J].
Corley, Douglas A. ;
Kubo, Ai ;
Zhao, Wei ;
Quesenberry, Charles .
GASTROENTEROLOGY, 2010, 139 (01) :93-101
[8]   Smoking, smoking cessation, and risk of hip fracture in women [J].
Cornuz, J ;
Feskanich, D ;
Willett, WC ;
Colditz, GA .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (03) :311-314
[9]   Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates [J].
de Vries, F. ;
Cooper, A. L. ;
Cockle, S. M. ;
van Staa, T-P. ;
Cooper, C. .
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (12) :1989-1998
[10]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188